Middle East and Africa Biopreservation Market Trends and Forecast Analysis 2021
The Middle-East & Africa is currently estimated to be a $122.6 Million market in 2016 and is forecasted to reach $199.2 million by 2021 with a significant growth rate of 10.2% in the review period
(EMAILWIRE.COM, December 08, 2017 ) The growing prevalence of chronic diseases like acute respiratory diseases, diabetes, cardiovascular diseases and cancer has increased the demand for biopreservation. Life sciences companies have been increasingly using biopreservation media to develop cell and tissue related therapies. Many large academic institutions, healthcare institutions, governments, bio technology and pharmaceutical companies are investing in bio banks and biorepositories clinical research.
Through biopreservation, biological samples are stored in an environment suitable for their survival. Biological samples that are stored through biopreservation typically include cells, plasma, tissues, saliva, organs and body fluids. Biobanks are leaning towards software tools and automated systems to improve management, storage and retrieval of HBS without sacrificing sample integrity and sustainability. With the growing volumes of human biological samples to be preserved, the storage space must be utilized efficiently.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-biopreservation-market-1013/request-sample
The biopreservation market is driven by a host of factors that include rising demand for preserving new-born’s stem cells, increasing healthcare expenditure, rising R&D investments on research advances in drug discovery, biobanks, regenerative market, investment by government and private corporations. The market is also aided by the advancements in the diagnostics and personalised medicines, increasing applications and new facilities in biopreservation. However, there are a few hurdles the market has to overcome that include stability issues of specimens and high cost pertaining to technologically advanced products in order for the market to sustain in the future.
The Middle-East & Africa biopreservation market is segmented based on the product type as biopreservation media, biopreservation equipment and lab information system management. Based on the bio-specimens, the market is categorised as human tissue samples, organs, stem cells and other bio-specimens. Based on application, biopreservation market is analysed as therapeutic applications, research applications, clinical trials and other applications. Based on the end-users, the market is segmented as biobanks, gene banks, hospitals and others. The Middle-East & Africa market is segmented based on the geographical region as Saudi Arabia, UAE, Israel and others.
The major players in the biopreservation industry are BioCision LLC, BioLife Solutions, Inc., Cesca Therapeutics Inc., Lifeline Scientific Inc., Panasonic Corporation, Sigma-Aldrich Corporation, So-Low Environmental Equipment Co., Taylor-Wharton, Thermo Fisher Scientific, Inc. and VWR Corporation.
Through biopreservation, biological samples are stored in an environment suitable for their survival. Biological samples that are stored through biopreservation typically include cells, plasma, tissues, saliva, organs and body fluids. Biobanks are leaning towards software tools and automated systems to improve management, storage and retrieval of HBS without sacrificing sample integrity and sustainability. With the growing volumes of human biological samples to be preserved, the storage space must be utilized efficiently.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-biopreservation-market-1013/request-sample
The biopreservation market is driven by a host of factors that include rising demand for preserving new-born’s stem cells, increasing healthcare expenditure, rising R&D investments on research advances in drug discovery, biobanks, regenerative market, investment by government and private corporations. The market is also aided by the advancements in the diagnostics and personalised medicines, increasing applications and new facilities in biopreservation. However, there are a few hurdles the market has to overcome that include stability issues of specimens and high cost pertaining to technologically advanced products in order for the market to sustain in the future.
The Middle-East & Africa biopreservation market is segmented based on the product type as biopreservation media, biopreservation equipment and lab information system management. Based on the bio-specimens, the market is categorised as human tissue samples, organs, stem cells and other bio-specimens. Based on application, biopreservation market is analysed as therapeutic applications, research applications, clinical trials and other applications. Based on the end-users, the market is segmented as biobanks, gene banks, hospitals and others. The Middle-East & Africa market is segmented based on the geographical region as Saudi Arabia, UAE, Israel and others.
The major players in the biopreservation industry are BioCision LLC, BioLife Solutions, Inc., Cesca Therapeutics Inc., Lifeline Scientific Inc., Panasonic Corporation, Sigma-Aldrich Corporation, So-Low Environmental Equipment Co., Taylor-Wharton, Thermo Fisher Scientific, Inc. and VWR Corporation.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results